Geode Capital Management, LLC Sellas Life Sciences Group, Inc. Transaction History
Geode Capital Management, LLC
- $1.24 Trillion
- Q1 2025
A detailed history of Geode Capital Management, LLC transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 820,440 shares of SLS stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
820,440
Previous 733,546
11.85%
Holding current value
$1.28 Million
Previous $740,000
19.73%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding SLS
# of Institutions
50Shares Held
14.4MCall Options Held
538KPut Options Held
26.3K-
Anson Funds Management LP Dallas, TX7.58MShares$11.8 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.84MShares$4.43 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA689KShares$1.07 Million0.0% of portfolio
-
Black Rock Inc. New York, NY430KShares$671,3740.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il350KShares$545,2270.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $32.1M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...